Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer
- PMID: 23225522
- DOI: 10.1002/cncr.27848
Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer
Abstract
Background: There is increasing concern regarding the financial burden of care on cancer patients and their families. Medicare beneficiaries often have extensive comorbidities and limited financial resources, and may face substantial cost sharing even with supplemental coverage. In the current study, the authors examined out-of-pocket (OOP) spending and burden relative to income for Medicare beneficiaries with cancer.
Methods: This retrospective, observational study pooled data for 1997 through 2007 from the Medicare Current Beneficiary Survey linked to Medicare claims. Medicare beneficiaries with newly diagnosed cancer were selected using claims-based diagnoses. Generalized linear models were used to estimate OOP spending. Logistic regression models identified factors associated with a high OOP burden, defined as spending > 20% of one's income during the cancer diagnosis and subsequent year.
Results: The cohort included 1868 beneficiaries with and 10,047 without cancer. Compared with the noncancer cohort, cancer patients were older, had more comorbidities, and were more likely to lack supplemental coverage. The mean OOP spending for cancer patients was $4727. Cancer patients faced an adjusted $976 (P < .01) incremental OOP spending. Greater than one-quarter (28%) of beneficiaries with cancer experienced a high OOP burden compared with 16% of beneficiaries without cancer (P < .001). Supplemental insurance and higher income were found to be protective against a high OOP burden, whereas assets, comorbidity, and receipt of cancer-directed radiation and antineoplastic therapy were associated with a higher OOP burden.
Conclusions: Medicare beneficiaries with cancer face a higher OOP burden than their counterparts without cancer; some of the higher burden was explained by the higher comorbidity burden and lack of supplemental insurance noted among these patients. Financial pressures may discourage some elderly patients from pursuing treatment.
Copyright © 2012 American Cancer Society.
Similar articles
-
Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.Health Serv Res. 1999 Apr;34(1 Pt 2):241-54. Health Serv Res. 1999. PMID: 10199672 Free PMC article.
-
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.JAMA Oncol. 2017 Jun 1;3(6):757-765. doi: 10.1001/jamaoncol.2016.4865. JAMA Oncol. 2017. PMID: 27893028 Free PMC article.
-
The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer.Value Health. 2014 Jan-Feb;17(1):15-21. doi: 10.1016/j.jval.2013.11.003. Value Health. 2014. PMID: 24438713
-
Patient out-of-pocket spending in cranial neurosurgery: single-institution analysis of 6569 consecutive cases and literature review.Neurosurg Focus. 2018 May;44(5):E6. doi: 10.3171/2018.1.FOCUS17782. Neurosurg Focus. 2018. PMID: 29712524 Review.
-
Expanding the Catalog of Patient and Caregiver Out-of-Pocket Costs: A Systematic Literature Review.Popul Health Manag. 2024 Feb;27(1):70-83. doi: 10.1089/pop.2023.0238. Epub 2023 Dec 13. Popul Health Manag. 2024. PMID: 38099925 Free PMC article. Review.
Cited by
-
Therapeutic potential of twenty-first century music for cancer survivorship: from music and conceptual metaphor perspectives to a synergetic effect approach.Support Care Cancer. 2024 Jul 17;32(8):520. doi: 10.1007/s00520-024-08719-5. Support Care Cancer. 2024. PMID: 39017779
-
Association of Medicare eligibility with access to and affordability of care among older cancer survivors.J Cancer Surviv. 2024 Mar 23:10.1007/s11764-024-01562-x. doi: 10.1007/s11764-024-01562-x. Online ahead of print. J Cancer Surviv. 2024. PMID: 38520599
-
Comparisons of financial hardship in cancer care by family structure and among those with and without minor children using nationally representative data.Cancer Med. 2024 Mar;13(6):e7088. doi: 10.1002/cam4.7088. Cancer Med. 2024. PMID: 38520136 Free PMC article.
-
Financial Toxicity in Breast Reconstruction: The Role of the Surgeon-Patient Cost-of-Care Discussion.Semin Plast Surg. 2024 Jan 19;38(1):39-47. doi: 10.1055/s-0043-1778040. eCollection 2024 Feb. Semin Plast Surg. 2024. PMID: 38495060 Review.
-
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).Ann Surg Oncol. 2024 Mar;31(3):1980-1989. doi: 10.1245/s10434-023-14577-y. Epub 2023 Dec 4. Ann Surg Oncol. 2024. PMID: 38044348
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
